ZEVRA THERAPEUTICS, INC. — Director's Dealing 2017

Jun 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2017-06-20

Reporting Person: Mickle Travis C (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-20	Common Stock	P	8000	$3.449	Acquired	17050	Indirect
2017-05-22	Common Stock	G	32269	—	Acquired	1629612	Direct
2017-05-22	Common Stock	G	18194	—	Acquired	1647806	Direct
2017-05-22	Common Stock	G	32269	—	Disposed	53638	Indirect
2017-05-22	Common Stock	G	18194	—	Disposed	141356	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	33614	Indirect
Common Stock	157197	Indirect
Common Stock	243880	Indirect
Common Stock	100604	Direct

Footnotes

F1: The Reporting Person and his spouse are the managing members of Mickle Investments, LLC.

F2: Held jointly with spouse.